Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...

NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...

Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...

Therapists who work in long-term care know a lot about time management and productivity. We know that our billable time must closely match our time on the ...

Q4 2024 Management View CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported ...

Zydus Lifesciences reported 29.62% jump in consolidated net profit of Rs 1,023.5 crore inQ3 FY25 compared with Rs 789.6 crore in Q3 FY24.

Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally ...

MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on ...

The company has crossed $100 million in annual recurring revenue as enterprises clean up their data to train AI models.

A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...

Alice Pope began her health system CFO career at an organization with less than $1 billion in revenue. Today, she is CFO of Novant Health, a Winston-Salem, N.C.-based health system that exceeded $10 ...

Glean, a maker of search chatbots and agents for businesses, has more than doubled its customer base in the last year alone, ...